OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
• Abstract Chimeric antigen receptor (CAR)-natural killer (NK) cell therapies hold promise for solid tumours but remain limited because of poor tumour infiltration, persistence and
• Abstract Chimeric antigen receptor (CAR)-natural killer (NK) cell therapies hold promise for solid tumours but remain limited because of poor tumour infiltration, persistence and
• In nature, tiny crystals known as nanocrystals are formed slowly over many years. • Rocks and minerals react with air, water, and carbon dioxide in a process called chemical weat
• Israeli cybersecurity firm Check Point Software Technologies (NASDAQ: CHKP) reported strong fourth-quarter and full-year 2025 financial performance while announcing three strateg